Rutgers toxicology chief understands urgency to develop chemical warfare antidotes

Currently, Dr. Jeffrey Laskin, director of the Rutgers University CounterACT Research Center of Excellence, leads a team conducting research on the exposure and health effects of chemical warfare agents used by terrorists. The researchers are determined to develop medical countermeasures. … Continue reading Rutgers toxicology chief understands urgency to develop chemical warfare antidotes